Helping you make wiser investment decisions

Pharmaceuticals, health and wellness

Pilot launch complete: GlaxoSmithKline’s malaria shot scores WHO backing for wider rollout in Africa

GlaxoSmithKline has spent many years developing and testing its world-first malaria vaccine, but even after a positive recommendation from European regulators in 2015, the shot still isn’t widely deployed. That’s set to change with the World Health Organization’s (WHO’s) blessing for the vaccine. Wednesday, the WHO recommended a wider use of the shot—known as RTS,S—in children in […]

With D.C. drug pricing negotiations still up in the air, the ‘endgame’ could still ‘have a bite,’ analyst says

With Democrats in Washington debating the specifics of the president’s infrastructure program, the pharmaceutical industry may be able to squeak out a much-desired drug pricing win. As the negotiations unfold, Politico reports that the party leadership may have to abandon its proposal to have Medicare negotiate drug prices. Federal drug pricing negotiations are a top […]

NICE backs Novartis’ Adakveo via special channel despite ‘high uncertainty’ about cost, long-term efficacy

When England’s drug economics reviewers say they’re not sure about a drug’s cost-effectiveness, that typically results in a rejection of coverage. But that’s not the case for Novartis’ sickle cell disease drug Adakveo. Tuesday, Adakveo won backing from the National Institute for Health and Care Excellence (NICE) as the first new therapy for sickle cell […]

Cancer survivors fear lymphedema. ImpediMed’s campaigning for testing that can prevent it

Imagine surviving cancer and then getting a new chronic disease as a side effect of treatment. That’s reality for cancer survivors who develop the limb-swelling complication lymphedema, which is caused by a buildup of lymphatic fluid. But as medical device maker ImpediMed points out in its first major consumer-facing campaign, testing and early detection can […]

As Revance nears a potential launch for its Botox rival, AbbVie sues for patent infringement

Revance Therapeutics has traveled a long road to a potential FDA approval for its Botox competitor, including COVID delays that pushed back plant inspections. Now, it faces a new obstacle: a patent lawsuit from drug giant AbbVie. AbbVie subsidiary Allergan on Friday sued Revance, alleging the company’s proposed frown-line injection daxibotulinumtoxinA infringes several Botox patents. An FDA decision […]

AstraZeneca underpaid hundreds of female and Hispanic sales reps, feds say

AstraZeneca already faced one high-profile personnel issue this year in a case that resulted in a $2.4 million jury award for a former sales manager. Now, the company is paying up to resolve allegations of race- and gender-based pay discrimination for hundreds of sales reps. As part of a routine investigation, U.S. authorities found that from October […]

Eli Lilly’s Olympics campaign rewind: Leverage pandemic’s focus on health to assert its brand and assert its point of view

When Eli Lilly signed on to be an Olympic sponsor for the Tokyo Games in 2019, the pandemic was of course yet to come. When COVID-19 did hit, the Games were postponed and the newly busy pharma industry dove into researching vaccines and therapies. But as successful vaccines and monoclonal antibody treatments came to market, […]

Agile Therapeutics scores soccer superstar Carli Lloyd to help build its women’s health brand

Agile Therapeutics and women’s soccer legend Carli Lloyd have a lot in common. They’re both from New Jersey, they’re both passionate about empowering women and they’ve both overcome setbacks on the path to success. “We think she lines up with our corporate spirit,” Al Altomari, CEO of the women’s health company, said in an interview. She […]

Is the cancer immunotherapy market up for disruption as AstraZeneca, Regeneron-Sanofi, cheaper Chinese offerings line up?

In the cancer immunotherapy market, Merck & Co. has established its Keytruda as the absolute leader. But AstraZeneca, a partnership between Regeneron and Sanofi plus several Chinese firms and their Western collaborators are all lining up their products for the most desirable piece of the cake: non-small cell lung cancer. Some new players are touting what […]

Fierce Pharma Asia—Biogen-Eisai’s Alzheimer’s drug filing; Samsung-Roche deal growth; Sunovion-Otsuka neuro pact

Biogen and Eisai hope to follow up on Aduhelm’s approval by seeking an accelerated nod from the FDA for another anti-amyloid Alzheimer’s disease candidate. Samsung Biologics has seen its long-term contract manufacturing partnership with Roche swell in value in the past eight years. Otsuka is licensing four clinical candidates for neuropsychiatric disorders from Sumitomo Dainippon Pharma’s Sunovion. And more. 1. […]

Moderna report says ‘human error’ to blame for contamination found in 3 vaccine lots from Rovi plant

Five weeks after Japan suspended the use of three lots of the Moderna COVID-19 vaccine, the company and its Japanese distributor Takeda have concluded (PDF) that “human error” caused the presence of metallic particles in vials. The errors occurred at a Rovi manufacturing plant in Spain, which released three vaccine lots after a fourth lot […]

Roche, Takeda and Pfizer notch top scores among rare disease patient advocacy groups

Rare disease patients are seeing pharma companies in a better light these days—thanks in part to the COVID-19 vaccine halo effect, according to PatientView’s latest survey of 230 rare disease patient advocacy groups. However, while some companies are doing better than others, there’s still a need for more transparency, better pricing and more patient engagement overall.  Fifty percent […]